Risk Factors for Eating Disorder Psychopathology within the Treatment Seeking Transgender Population: The Role of Cross‐Sex Hormone Treatment

Publisher: John Wiley & Sons Inc

E-ISSN: 1099-0968|26|2|120-128

ISSN: 1072-4133

Source: EUROPEAN EATING DISORDERS REVIEW, Vol.26, Iss.2, 2018-03, pp. : 120-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

AbstractMany transgender people experience high levels of body dissatisfaction, which is one of the numerous factors known to increase vulnerability to eating disorder symptoms in the cisgender (non‐trans) population. Cross‐sex hormones can alleviate body dissatisfaction so might also alleviate eating disorder symptoms. This study aimed to explore risk factors for eating disorder symptoms in transgender people and the role of cross‐sex hormones. Individuals assessed at a national transgender health service were invited to participate (N = 563). Transgender people not on cross‐sex hormones reported higher levels of eating disorder psychopathology than people who were. High body dissatisfaction, perfectionism, anxiety symptoms, and low self‐esteem were risk factors for eating psychopathology, but, after controlling for these, significant differences in eating psychopathology between people who were and were not on cross‐sex hormones disappeared. Cross‐sex hormones may alleviate eating disorder psychopathology. Given the high prevalence of transgender identities, clinicians at eating disorder services should assess for gender identity issues. Copyright © 2018 John Wiley Sons, Ltd and Eating Disorders Association.